Crystal Diagnostics Granted New Patent for Rapid Detection of Foodborne Pathogens

/in , /by

A fully automated, high throughput rapid pathogen detection platform is scheduled for market release in April 2020 Crystal Diagnostics (CDx) announced today that the US Patent and Trademark Office (USPTO) issued the company a second patent related to proprietary liquid crystal technology for rapid and accurate detection of foodborne pathogens. The Notice of Allowance complements […]

Read more →

Cellectricon and StressMarq Biosciences collaborate to develop next generation reagents and assays to advance neurodegenerative disease research

/in , , , /by

MOLNDAL, SWEDEN and VICTORIA, BC, CANADA – Cellectricon, a collaborative services provider dedicated to advancing drug discovery and research in the areas of chronic pain and neurodegenerative diseases announces a collaboration with StressMarq Biosciences. As a supplier of life science reagents such as primary antibodies, antibody conjugates, proteins, immunoassay kits and small molecules, Stressmarq Biosciences will […]

Read more →

RedShiftBio Appoints Julien Bradley as CEO and Closes $18M Series D Round Funding

/in , /by

New CEO and additional funding come as installations of its AQS3pro™ platform gain momentum at leading biopharmaceutical customers in US and Europe Burlington, MA — RedShift BioAnalytics, Inc. (RedShiftBio), a provider of innovative analytical solutions for protein characterization used in biotherapeutic drug development, is pleased to announce the appointment of Julien Bradley as Chief Executive […]

Read more →

INDIGO Biosciences Announces Record Revenue Numbers for 2019

/in , , , , /by

STATE COLLEGE, Pa. — INDIGO Biosciences, Inc. (INDIGO), the recognized industry leader in nuclear receptor and in vitro toxicology testing solutions, has announced a record earnings year for 2019. With final numbers to be released to Company Shareholders in the upcoming weeks, INDIGO showed more than a twenty percent increase in revenue and a thirty percent […]

Read more →

Salimetrics Launches New Salivary Human Total Immunoglobulin G (IgG) ELISA Kit to Support Multidisciplinary Investigators in Serological Studies

/in , , , /by

STATE COLLEGE, Pa. — Today, Salimetrics announced an addition to their trusted line of Better Salivary Assay Kits. The new Salivary Total Human IgG Assay Kit exemplifies Salimetrics’ 20+ year commitment to cutting-edge salivary bioscience research. “By measuring total immunoglobulin G in saliva, researchers can extend the accuracy and ease of use of salivary bioscience into infectious disease […]

Read more →

Three Industry Leaders Form New Venture to Create Scalable Manufacturing Platforms for Cell and Gene Therapies

/in , , , , /by

Bio-Techne, Fresenius Kabi, and Wilson Wolf have formed a new joint venture company to provide dedicated support to researchers and biopharmaceutical companies in the field of cell and gene therapy. The joint venture will focus on providing scalable manufacturing technologies and processes needed to develop and commercialize new cell and gene therapies. Each of the […]

Read more →

Biotage completes the acquisition of PhyNexus, Inc. and resolves on a share issue as part of the acquisition

/in , , , /by

Stockholm – Biotage AB (publ) (Biotage) has today completed the acquisition of PhyNexus, Inc. (PhyNexus), which was announced on December 4, 2018. As part of the completion, the Board of Directors of Biotage has also, pursuant to an authorization granted by the Annual General Meeting 2018, resolved on a share issue of 487,337 shares. As […]

Read more →

Carterra® Closes Financing Round for Continued Growth of the LSA™ Platform for Next Generation Antibody Discovery

/in , /by

Additional Resources Will Support New Product Development and Global Expansion Salt Lake City, Utah, USA. Carterra® Inc., the world leader in high-throughput antibody screening and characterization, has closed a $6M round of financing led by Ballast Point Ventures with participation from current investor, Telegraph Hill Partners. The additional funding will support the continued adoption of the […]

Read more →

Nicoya Raises $10 Million in Series A Funding to Make Drug Discovery Digital

/in , /by

KITCHENER, ON – Nicoya, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, announced today that it has raised $10 million in Series A financing. The funding round was led by Whitecap Venture Partners with participation from existing investors, including Garage Capital, MaRS IAF, Laurier Startup Fund, University of Waterloo Student Venture Fund, and others. […]

Read more →

ReadCoor, Inc. Announces $27 Million Series B Financing for Commercial Launch of 3D RNA, DNA, and Protein Spatial Sequencing Platform

/in , , , /by

ReadCoor’s technology simultaneously detects hundreds to thousands of RNA, DNA, proteins, and therapeutics in every cell within intact tissue Spatially surveying thousands of molecules simultaneously drives meaningful insights into disease states and treatment effects Spatial analysis across multiple omic formats gives researchers new insights into cancer, immuno-oncology, gene therapy, and neurodegenerative diseases CAMBRIDGE, Mass., January […]

Read more →